eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
4/2021
vol. 72
 
Share:
Share:
more
 
 
abstract:
Original paper

Prognostic importance of molecular-like classification in gastroesophageal junction tumors (Izmir Oncology Group [IZOG] study)

Özlem Özdemir
1
,
Asuman Argon
2
,
Savaş Yakan
3
,
Tarık Salman
4
,
Ahmet AlacacIoğlu
4

1.
Department of Medical Oncology, Izmir Bozyaka Education and Research Hospital, The University of Health Sciences, Turkey
2.
Department of Medical Pathology, Izmir Bozyaka Education and Research Hospital, The University of Health Sciences, Izmir, Turkey
3.
Department of General Surgery, Izmir Bozyaka Education and Research Hospital, The University of Health Sciences, Izmir, Turkey
4.
Department of Medical Oncology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey
Pol J Pathol 2021; 73 (4): 315-323
Online publish date: 2022/03/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
A comprehensive molecular classification was published in 2014 within The Cancer Genome Atlas (TCGA) to guide clinical approaches and treatment strategies. This study aimed to investigate the clinicopathological and prognostic importance of the classification using immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) to identify potential surrogate markers of molecular changes in gastroesophageal junction (GEJ) adenocarcinomas.

A total of 52 GEJ adenocarcinomas were divided into five groups using IHC with MLH-1, E-cadherin, p53 and CISH with EBER: 1) microsatellite unstable (MSI: negative with MLH-1), 2) genomically stable tumors (GS: positive with p53),

3) chromosomally unstable tumors (CUN: negative with e-cadherin), 4) EBV+ tumors (EBV+: positive with EBER) and 5) unclassifiable (G-NOS: MLH-1 and e-cadherin positive with p53 and negative with EBER).

The largest group consisted of 24 (46.2%) cases of CUN tumors. This group was followed by groups of GS with 14 (26.9%) cases, MSI with 7 (13.5%) cases, and EBV + with 3 (5.8%) cases, respectively. Although this classification was not associated with pathological features, it was found to be closely related to prognosis (p = 0.029). Patients with EBV+ tumors had the longest overall survival, followed by the G-NOS, MSI, CUN, GS groups.
keywords:

gastroesophageal junction adenocarcinoma, molecular classification, The Cancer Genome Atlas, immunohistochemical analysis, chromogenic in situ hybridization

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.